Search

everythinglearnresearchcommunity

for

Search:↓

Masculinization in affected individuals occurs gradually after puberty due to hormone changes.

PRP treatment improves hair growth, and the device used can affect results, with some being more effective.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

Finasteride effectively treats male pattern baldness, improving hair growth and density.

5α-reductase inhibitors, like finasteride and dutasteride, effectively treat BPH, male baldness, and hirsutism, with potential for acne and prostate cancer prevention.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

High AMH levels are linked to PCOS in women and may have a male equivalent with similar traits.

Finasteride effectively treats enlarged prostate and male baldness, improves symptoms of hirsutism in women, but doesn't work for acne, and may delay prostate cancer progression with few side effects.

New oral treatment, finasteride, effectively and safely treats common hair loss.

Finasteride and Dutasteride can improve hair growth in male baldness but may cause temporary sexual dysfunction and possibly affect fertility.

Hormonal treatments can help with hair loss, acne, and excess hair growth, but it takes 3-6 months to see results and patients should know the possible side effects.

Male and female skin differ due to hormones, affecting conditions like hair loss, acne, and skin cancer, and suggesting a need for gender-specific treatments.

PNU157706 reduced rat sperm movement and fertility without affecting offspring health.

Cholesterol balance is important for hair health, and problems with it can lead to hair loss conditions.

Finasteride causes lasting fertility decrease in rats.

Gene mutations can cause problems in male genital development.

Hormonal therapy is a treatment option for acne, the only medical treatment for hirsutism, and the most promising for androgenetic alopecia.

5α-Reductase inhibitors can help treat hair loss, acne, and prostate issues by reducing DHT levels.

Antiandrogens affect androgen-dependent body functions and are used for various medical conditions, with some risks like fetus feminization, but new forms like 17α-propylmesterolone show promise for acne without systemic effects.

The girl's unexpected pubic hair growth led to a diagnosis different from complete androgen insensitivity syndrome.

Lanugo hair develops earlier on the back than the front of human fetuses.

Early androgen exposure affects hormone receptor expression in adult female rats' brains, but not in males.

Blocking androgen activity in newborn rats affects body weight and appetite-related hormones differently in males and females.

Topical treatments can regrow hair on bald scalps.

Autism's genetics are linked with early age of puberty and less hair loss, but not with hormone levels or polycystic ovary syndrome.

Hair loss in Androgenetic Alopecia is caused by genetics, aging, and lifestyle, leading to hair follicle shrinkage and related health risks.

Male sexual differentiation is regulated independently, while female differentiation occurs in an androgenic environment, affecting conditions like congenital adrenal hyperplasia.

Male and female bodies respond differently to stress, influenced by hormones and development stages, with implications for stress-related diseases.

Insulin resistance and high male hormone levels are major causes of Polycystic Ovary Syndrome.

The meeting highlighted promising genetic treatments for male fertility issues but noted concerns about certain cancer risks and ICSI safety.